statistiche ricercatore

Continente	#
NA - Nord America	955
EU - Europa	386
AS - Asia	142
SA - Sud America	3
Continente sconosciuto - Info sul continente non disponibili	2
OC - Oceania	1
Totale	1.489

Nazione	#
US - Stati Uniti d'America	952
IT - Italia	119
GB - Regno Unito	91
SE - Svezia	54
CN - Cina	42
SG - Singapore	42
DE - Germania	35
FI - Finlandia	21
HK - Hong Kong	19
TR - Turchia	18
FR - Francia	16
ID - Indonesia	11
UA - Ucraina	10
BG - Bulgaria	8
CZ - Repubblica Ceca	6
IE - Irlanda	4
NL - Olanda	4
BE - Belgio	3
CA - Canada	3
IN - India	3
LT - Lituania	3
VN - Vietnam	3
AE - Emirati Arabi Uniti	2
CO - Colombia	2
DK - Danimarca	2
ES - Italia	2
RU - Federazione Russa	2
SK - Slovacchia (Repubblica Slovacca)	2
A1 - Anonimo	1
AT - Austria	1
AU - Australia	1
BD - Bangladesh	1
BR - Brasile	1
EU - Europa	1
GR - Grecia	1
IR - Iran	1
RS - Serbia	1
SI - Slovenia	1
Totale	1.489

Nome	#
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study	255
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study	223
Mucorales-specific T cells in patients with hematologic malignancies	216
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia	212
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers	184
A typical atypical chronic myeloid leukemia	172
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study	156
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study	71
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients	27
Totale	1.516

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	216	0	0	0	0	0	34	76	32	27	23	12	12
2020/2021	315	18	13	14	64	34	23	10	39	16	39	28	17
2021/2022	169	7	11	21	5	6	13	6	16	14	13	41	16
2022/2023	242	30	35	15	25	36	33	8	18	13	5	10	14
2023/2024	171	4	3	17	17	21	23	15	31	0	3	14	23
2024/2025	191	16	9	10	32	75	49	0	0	0	0	0	0
Totale													1.516